Topics covered: Tuck-in acquisitions, Stocks to avoid., Stock recommendations, Stock price performance, Role of Big Pharma, Pharmaeconomics, PDUFA dates, Off-patent drugs, M&A outlook, Hybrid companies, Higher costs of drug development, Financing environment, FDA actions, Asset sales from small cap biotechs